Steven Cohen Rigel Pharmaceuticals Inc Transaction History

Point72 Asset Management, L.P.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$1.25 - $2.0 $938 - $1,502	751 New	751 $0
Q2 2021 Aug 16, 2021	SELL	$3.09 - $4.54 $3.59 Million - $5.27 Million	-1,160,900 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$3.35 - $4.93 $3.89 Million - $5.72 Million	1,160,900 New	1,160,900 $3.97 Million

334K

Ticker RIGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 172,836,000
Market Cap $2.84B
Description
Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.